Immunodeficiency Clinical Trials in San Francisco, California
5 recruitingSan Francisco, California
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled78 locationsNCT07044297
Recruiting
Not Applicable
Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release
HIV (Human Immunodeficiency Virus)
University of California, San Francisco33 enrolled1 locationNCT07115901
Recruiting
Phase 1Phase 2
Autologous Gene Therapy for Artemis-Deficient SCID
Severe Combined Immunodeficiency
University of California, San Francisco24 enrolled1 locationNCT03538899
Recruiting
Phase 2
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Interstitial Lung DiseaseCommon Variable Immunodeficiency
Children's Hospital Medical Center, Cincinnati38 enrolled6 locationsNCT04925375
Recruiting
Not Applicable
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Cardiovascular DiseasesAtherosclerosisHIV+1 more
University of California, San Francisco260 enrolled2 locationsNCT05642858